These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38869144)

  • 1. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
    Eur J Prev Cardiol; 2024 Nov; 31(15):1863-1875. PubMed ID: 38869144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Yokoyama Y; Kuno T; Morita SX; Slipczuk L; Takagi H; Briasoulis A; Latib A; Bangalore S; Heffron SP
    J Cardiol; 2022 Nov; 80(5):416-422. PubMed ID: 35914996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.
    Marik PE; Varon J
    Clin Cardiol; 2009 Jul; 32(7):365-72. PubMed ID: 19609891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. n-3 fatty acids and cardiovascular events after myocardial infarction.
    Kromhout D; Giltay EJ; Geleijnse JM;
    N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acid supplementation for depression in children and adolescents.
    Campisi SC; Zasowski C; Bradley-Ridout G; Schumacher A; Szatmari P; Korczak D
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD014803. PubMed ID: 39564892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
    Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
    Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Kwak SM; Myung SK; Lee YJ; Seo HG;
    Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
    Lavie CJ; Milani RV; Mehra MR; Ventura HO
    J Am Coll Cardiol; 2009 Aug; 54(7):585-94. PubMed ID: 19660687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
    Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
    Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
    Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
    J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 fatty acids and cardiovascular disease.
    Breslow JL
    Am J Clin Nutr; 2006 Jun; 83(6 Suppl):1477S-1482S. PubMed ID: 16841857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.
    Sarmento Vasconcelos V; Macedo CR; de Souza Pedrosa A; Pereira Gomes Morais E; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011014. PubMed ID: 27536971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.